Multilevel Interventions to Increase Adherence to Lung Cancer Screening
Larch
1 other identifier
interventional
1,837
1 country
1
Brief Summary
Screening for lung cancer has the potential for a profound public health benefit. Repeat annual screening is necessary for early detection of lung cancer. The investigators will test two interventions which include patient education and reminders to improve adherence to lung cancer screening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable lung-cancer
Started Dec 2022
Typical duration for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 12, 2022
CompletedFirst Submitted
Initial submission to the registry
February 17, 2023
CompletedFirst Posted
Study publicly available on registry
February 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 5, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedDecember 24, 2025
December 1, 2025
2.6 years
February 17, 2023
December 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of repeat annual lung cancer screening
Electronic health records will be searched for screening low dose CT (LDCT).
9-15 months after index LDCT
Secondary Outcomes (2)
Knowledge of lung cancer screening
8 weeks after index LDCT
Attitudes and beliefs
8 weeks after index LDCT
Study Arms (4)
Patient Video only
EXPERIMENTALAbout 3 weeks after the index LDCT, the study Medical Assistant (MA) will deliver a link to the Patient Voices Video, an educational video about lung cancer screening.
Stepped Reminders only
EXPERIMENTALPrior to patient's next LDCT scan is due, MA begins Stepped Reminders intervention: MA pends LDCT orders to PCP to sign. MA sends reminders to patient when order is placed and follows up by phone if patient has not scheduled LDCT.
Patient Video and Stepped Reminders
EXPERIMENTALSee above. Those assigned to the Patient Video and Stepped Reminders will receive both interventions, as described above.
Usual Care
NO INTERVENTIONThose assigned to the the Usual Care arm will continue to receive usual lung cancer screening care.
Interventions
Stepped Reminders, which directly reminds providers to order the next LDCT scan and then reminds patients they are due and prompts them to schedule LDCT with Radiology.
The Patient Voices Video is an educational video about lung cancer screening.
Eligibility Criteria
You may qualify if:
- KPWA members
- Aged 50-78 years
- Have a negative screening LDCT scan
- Speak English or Spanish
- Meet US Preventive Services Task Force guidelines
You may not qualify if:
- Patients who were previously diagnosed with lung cancer,
- Patients who have a positive scan,
- Patients who have an indicator for interpreter services, except for Spanish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kaiser Permanentelead
- Fred Hutchinson Cancer Centercollaborator
- Hackensack Meridian Healthcollaborator
Study Sites (1)
Kaiser Permanente
Seattle, Washington, 98101, United States
Related Publications (3)
Vasavada A, Palazzo L, Luce C, Sanchez M, Triplette M, Ralston JD, Carter-Bawa L, Green BB, Gao H, Li CI, Anderson ML, Su YR, Rogers K, Wernli KJ. "It's coming whether we want it to or not": A qualitative exploration of older adults' comfort with and perceptions of technology and digital health. Res Sq [Preprint]. 2025 Nov 19:rs.3.rs-8001649. doi: 10.21203/rs.3.rs-8001649/v1.
PMID: 41333381DERIVEDWernli KJ, Anderson ML, Palazzo L, Luce C, Bezman N, Chin M, Gao H, Ralston JD, Rogers K, Su YR, Triplette M, Carter-Bawa L, Vasavada A, Jordan M, West M, Boler S, Green BB. Effectiveness of Health Communication Intervention to Improve Knowledge on Timeliness to Return for Annual Lung Cancer Screening: The Larch Trial. Chest. 2026 Feb;169(2):550-561. doi: 10.1016/j.chest.2025.07.4111. Epub 2025 Sep 10.
PMID: 40939933DERIVEDLuce C, Palazzo L, Anderson ML, Carter-Bawa L, Gao H, Green BB, Ralston JD, Rogers K, Su YR, Tuzzio L, Triplette M, Wernli KJ. A pragmatic randomized clinical trial of multilevel interventions to improve adherence to lung cancer screening (The Larch Study): Study protocol. Contemp Clin Trials. 2024 May;140:107495. doi: 10.1016/j.cct.2024.107495. Epub 2024 Mar 11.
PMID: 38467273DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karen Wernli, PhD
Kaiser Permanente
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 17, 2023
First Posted
February 28, 2023
Study Start
December 12, 2022
Primary Completion
July 5, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
December 24, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share